Literature DB >> 29265398

Process Improvement for Maximized Therapeutic Innovation Outcome.

Scott A Waldman1, Andre Terzic2.   

Abstract

Deconvoluting key biological mechanisms forms the framework for therapeutic discovery. Strategies that enable effective translation of those insights along the development and regulatory path ultimately drive validated clinical application in patients and populations. Accordingly, parity in What vs. How we transform novel mechanistic insights into therapeutic paradigms is essential in achieving success. Aligning molecular discovery with innovations in structures and processes along the discovery-development-regulation-utilization continuum maximizes the return on public and private investments for next-generation solutions in managing health and disease.
© 2017 ASCPT.

Entities:  

Mesh:

Year:  2018        PMID: 29265398      PMCID: PMC5745039          DOI: 10.1002/cpt.929

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

1.  Precision Medicine.

Authors:  M Pacanowski; S M Huang
Journal:  Clin Pharmacol Ther       Date:  2016-02       Impact factor: 6.875

Review 2.  Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.

Authors:  N Shaheen; A Shiti; L Gepstein
Journal:  Clin Pharmacol Ther       Date:  2017-08       Impact factor: 6.875

Review 3.  Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Authors:  H M Jones; Y Chen; C Gibson; T Heimbach; N Parrott; S A Peters; J Snoeys; V V Upreti; M Zheng; S D Hall
Journal:  Clin Pharmacol Ther       Date:  2015-01-09       Impact factor: 6.875

Review 4.  Molecular "Sameness" Is the Key Guiding Principle for Extrapolation to Multiple Indications.

Authors:  M McCamish; G R Woollett
Journal:  Clin Pharmacol Ther       Date:  2017-03-22       Impact factor: 6.875

5.  Affairs of the Heart: Innovation in Cardiovascular Research and Development.

Authors:  P Honig; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-08       Impact factor: 6.875

Review 6.  Genome Editing Techniques and Their Therapeutic Applications.

Authors:  M P Calos
Journal:  Clin Pharmacol Ther       Date:  2016-11-18       Impact factor: 6.875

Review 7.  Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science.

Authors:  K Venkatakrishnan; J A Ecsedy
Journal:  Clin Pharmacol Ther       Date:  2016-11-25       Impact factor: 6.875

Review 8.  Engineered Heart Repair.

Authors:  B Fujita; W-H Zimmermann
Journal:  Clin Pharmacol Ther       Date:  2017-06-29       Impact factor: 6.875

9.  Addressing Pharmaceutical Injuries: The US Landscape.

Authors:  Cecilia Bakker; Nicholaas Honig
Journal:  Clin Pharmacol Ther       Date:  2017-08-29       Impact factor: 6.875

10.  Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.

Authors:  Walter K Kraft; Susan C Adeniyi-Jones; Inna Chervoneva; Jay S Greenspan; Diane Abatemarco; Karol Kaltenbach; Michelle E Ehrlich
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

View more
  4 in total

Review 1.  Phase 0/microdosing approaches: time for mainstream application in drug development?

Authors:  Tal Burt; Graeme Young; Wooin Lee; Hiroyuki Kusuhara; Oliver Langer; Malcolm Rowland; Yuichi Sugiyama
Journal:  Nat Rev Drug Discov       Date:  2020-09-08       Impact factor: 84.694

2.  Health Care Evolves From Reactive to Proactive.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2019-01       Impact factor: 6.875

Review 3.  Regenerative medicine clinical readiness.

Authors:  Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  Regen Med       Date:  2021-02-24       Impact factor: 3.806

4.  The Regenerative Horizon: Opportunities for Nursing Research and Practice.

Authors:  Linda L Chlan; Cindy Tofthagen; Andre Terzic
Journal:  J Nurs Scholarsh       Date:  2019-09-30       Impact factor: 3.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.